06 Dec 2021 New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster Member news
06 Dec 2021 Celyad Oncology announces $32.5 million private placement with Fortress Investment Group Member news
22 Nov 2021 OXURION NV secures EUR 10 million convertible bond financing from Kreos Capital and Pontifax Ventures Member news
20 Oct 2021 Biotalys awarded multi-year grant to develop new biological solutions for cowpea and other legumes Member news
12 Oct 2021 Rejuvenate Biomed raises a EUR 15.7 million Series B to accelerate clinical development of its sarcopenia treatment for healthy aging Member news
01 Oct 2021 S-Biomedic announces completion of prestigious financing with European Innovation Council Fund Member news
09 Sep 2021 Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases Member news
03 Sep 2021 Novalis Biotech Acceleration invests in San Francisco-based Modality.AI - technology that ‘self-drives’ neurological and psychiatric assessments Member news
15 Jul 2021 Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
